290 related articles for article (PubMed ID: 29065423)
1. Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.
Rouiller-Braunschweig C; Fournier N; Pittet V; Dudler J; Michetti P
Digestion; 2017 Nov; 96(4):220-227. PubMed ID: 29065423
[TBL] [Abstract][Full Text] [Related]
2. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center.
Willot S; Noble A; Deslandres C
Inflamm Bowel Dis; 2011 Dec; 17(12):2521-6. PubMed ID: 21337668
[TBL] [Abstract][Full Text] [Related]
4. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
Cholapranee A; Hazlewood GS; Kaplan GG; Peyrin-Biroulet L; Ananthakrishnan AN
Aliment Pharmacol Ther; 2017 May; 45(10):1291-1302. PubMed ID: 28326566
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate in ulcerative colitis: a Spanish multicentric study on clinical use and efficacy.
Mañosa M; García V; Castro L; García-Bosch O; Chaparro M; Barreiro-de Acosta M; Carpio D; Aguas M
J Crohns Colitis; 2011 Oct; 5(5):397-401. PubMed ID: 21939912
[TBL] [Abstract][Full Text] [Related]
6. Vedolizumab Induces Long-term Mucosal Healing in Patients With Crohn's Disease and Ulcerative Colitis.
Noman M; Ferrante M; Bisschops R; De Hertogh G; Van den Broeck K; Rans K; Rutgeerts P; Vermeire S; Van Assche G
J Crohns Colitis; 2017 Sep; 11(9):1085-1089. PubMed ID: 28369329
[TBL] [Abstract][Full Text] [Related]
7. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
Klimczak K; Łykowska-Szuber L; Krela-Kaźmierczak I; Eder P; Szymczak A; Stawczyk-Eder K; Linke K
Wiad Lek; 2016; 69(2 Pt 2):262-6. PubMed ID: 27487545
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
Huang Z; Chao K; Li M; Zhi M; Tang J; Hu P; Gao X
Inflamm Bowel Dis; 2017 Mar; 23(3):440-447. PubMed ID: 28129286
[TBL] [Abstract][Full Text] [Related]
10. Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease.
Rispo A; Testa A; De Palma GD; Donetto S; Diaferia M; Musto D; Nardone O; Maione F; Caporaso N; Castiglione F
Inflamm Bowel Dis; 2015 Nov; 21(11):2570-5. PubMed ID: 26222340
[TBL] [Abstract][Full Text] [Related]
11. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
Nathan DM; Iser JH; Gibson PR
J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
[TBL] [Abstract][Full Text] [Related]
12. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD.
Molander P; Sipponen T; Kemppainen H; Jussila A; Blomster T; Koskela R; Nissinen M; Rautiainen H; Kuisma J; Kolho KL; Färkkilä M
J Crohns Colitis; 2013 Oct; 7(9):730-5. PubMed ID: 23182163
[TBL] [Abstract][Full Text] [Related]
13. The pharmacogenetics of methotrexate in inflammatory bowel disease.
Herrlinger KR; Cummings JR; Barnardo MC; Schwab M; Ahmad T; Jewell DP
Pharmacogenet Genomics; 2005 Oct; 15(10):705-11. PubMed ID: 16141796
[TBL] [Abstract][Full Text] [Related]
14. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
[TBL] [Abstract][Full Text] [Related]
15. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
16. Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers.
Tursi A; Mocci G; Faggiani R; Allegretta L; Valle ND; Medici A; Forti G; Franceschi M; Ferronato A; Gallina S; Grasso G; Larussa T; Luzza F; Lorenzetti R; Penna A; Rodino' S; Sebkova L; Lauria A; Piergallini S; Pranzo G; Scorza S; Zampaletta C; Picchio M; Elisei W
Eur J Intern Med; 2019 Aug; 66():85-91. PubMed ID: 31208827
[TBL] [Abstract][Full Text] [Related]
17. Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing.
Boland K; Greener T; Kabakchiev B; Stempak J; Tessolini J; Li R; Soriano J; Croitoru K; Nguyen G; Steinhart AH; Weizman AV; Silverberg MS
Inflamm Bowel Dis; 2020 Apr; 26(5):766-773. PubMed ID: 31676891
[TBL] [Abstract][Full Text] [Related]
18. Mucosal healing did not predict sustained clinical remission in patients with IBD after discontinuation of one-year infliximab therapy.
Dai C; Liu WX; Jiang M; Sun MJ
PLoS One; 2014; 9(10):e110797. PubMed ID: 25330148
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
Afzali A; Park CJ; Zhu K; Hu JK; Sharma P; Sinanan MN; Lee SD
Inflamm Bowel Dis; 2016 Aug; 22(8):1887-95. PubMed ID: 27057681
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
Sokol H; Seksik P; Carrat F; Nion-Larmurier I; Vienne A; Beaugerie L; Cosnes J
Gut; 2010 Oct; 59(10):1363-8. PubMed ID: 20587545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
